Anthropometric Indices and Metabolic Dysfunction–Associated Fatty Liver Disease in Males and Females Living With Severe Obesity
Canadian Journal of Gastroenterology and Hepatology · 2025
DOI: 10.1155/cjgh/5545227 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Gastroenterology and Hepatology, 2025. Verfasst von Fannie Lajeunesse-Trempe und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Specialized Medicine, Internal Medicine, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada. Hauptthemen laut MEDLINE: Obesity, Morbid, Fatty Liver. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal College of Physicians and Surgeons of Canada.
Abstract (Originalsprache)
Introduction
Metabolic dysfunction–associated fatty liver disease (MAFLD) is highly prevalent among people living with severe obesity (body mass index [BMI] ≥ 35 kg/m 2 ). However, it remains unknown how sex and adipose tissue distribution are related to MAFLD onset and progression into metabolic dysfunction–associated steatohepatitis (MASH) or advanced stages of fibrosis. Methodology: We retrospectively studied patients with severe obesity who were eligible for bariatric surgery. Demographic characteristics, biomarkers, and cardiometabolic comorbidities were reported. Anthropometric indices such as BMI, waist circumference (WC), waist‐to‐hip ratio (WHR), waist‐to‐height ratio (WHtR), neck circumference (NC), lipid accumulation product (LAP), visceral adiposity index (VAI), body adiposity index (BAI), abdominal volume index (AVI), and body roundness index (BRI) were measured or calculated. MAFLD, MASH, and stages of fibrosis (F1‐F4) were established from perioperative liver biopsies. Standardized univariate and multivariate logistic regression analyses were used to examine the association between demographic variables, anthropometric indices, cardiometabolic conditions, and the risk of MASH or severe fibrosis (F2‐F4).
Results
A total of 2091 participants with severe obesity were included in the analyses; BMI 47.9 ± 7.3 kg/m 2 , age 46.2 ± 11.2 years, and 68.4% females. Overall, MAFLD prevalence was 79.5%, with 44.5% having MASH and 24.4% having severe fibrosis (Stage 2 or higher). No anthropometric indices of adiposity were associated with MASH or fibrosis severity. In this population, female sex was a risk factor for severe fibrosis (OR: 1.27, 95% CI 1.01–1.59, p < 0.05).
Conclusions
MAFLD and MASH are highly prevalent in individuals living with severe obesity, but no anthropometric indices or laboratory tests are good predictors of MAFLD or MASH in this population. When MAFLD is diagnosed, our results suggest that females with severe obesity might be at higher risk of advanced stages of fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Specialized Medicine, Internal Medicine, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.
- Faculty of Agriculture and Food Sciences, School of Nutrition, Laval University, Quebec City, Quebec, Canada.
- Faculty of Life Sciences and Medicine, School of Cardiovascular and Metabolic Medicine & Sciences, King's College London, London, UK.
- Department of Medicine, Laval University, Quebec City, Quebec, Canada.
- Department of Endocrinology, King's College Hospital NHS Foundation Trust, London, UK.
- Department of Surgery, Laval University, Quebec City, Quebec, Canada.
ORCID-Profile: Marie-Eve Piché, Laurent Biertho, André Tchernof
Förderung
- Royal College of Physicians and Surgeons of Canada
Zitieren
APA
Lajeunesse-Trempe, F., Dugas, S., Maltais-Payette, I., Tremblay, È. J., Piché, M. E., Dimitriadis, G. K., Lafortune, A., Marceau, S., Biertho, L., & Tchernof, A. (2025). Anthropometric Indices and Metabolic Dysfunction–Associated Fatty Liver Disease in Males and Females Living With Severe Obesity. Canadian Journal of Gastroenterology and Hepatology. https://doi.org/10.1155/cjgh/5545227
Vancouver
Lajeunesse-Trempe F, Dugas S, Maltais-Payette I, Tremblay ÈJ, Piché ME, Dimitriadis GK, et al. Anthropometric Indices and Metabolic Dysfunction–Associated Fatty Liver Disease in Males and Females Living With Severe Obesity. Canadian Journal of Gastroenterology and Hepatology. 2025. doi:10.1155/cjgh/5545227
BibTeX
@article{LajeunesseTrempe2025,
author = {Lajeunesse-Trempe, Fannie and Dugas, Selena and Maltais-Payette, Ina and Tremblay, Ève-Julie and Piché, Marie-Eve and Dimitriadis, Georgios K and Lafortune, Annie and Marceau, Simon and Biertho, Laurent and Tchernof, André},
title = {Anthropometric Indices and Metabolic Dysfunction–Associated Fatty Liver Disease in Males and Females Living With Severe Obesity},
journal = {Canadian Journal of Gastroenterology and Hepatology},
year = {2025},
doi = {10.1155/cjgh/5545227}
}
EUVIMED